These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 13281113)

  • 1. [Potentiation of the antibiotic properties of streptomycin regarding Brucella melitensis by a new antibiotic, oxamycin].
    LEON AP; DE LOURDES TRONCOSO M
    Rev Inst Salubr Enferm Trop; 1955 Jun; 15(2):57-72. PubMed ID: 13281113
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial susceptibility of
    Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
    Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region.
    Tanyel E; Coban AY; Koruk ST; Simsek H; Hepsert S; Cirit OS; Tulek N
    Saudi Med J; 2007 Aug; 28(8):1239-42. PubMed ID: 17676210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigecycline: its potential for treatment of brucellosis.
    Dizbay M; Kilic S; Hizel K; Arman D
    Scand J Infect Dis; 2007; 39(5):432-4. PubMed ID: 17464866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline.
    Seleem MN; Jain N; Pothayee N; Ranjan A; Riffle JS; Sriranganathan N
    FEMS Microbiol Lett; 2009 May; 294(1):24-31. PubMed ID: 19493005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility testing of Brucella melitensis isolated from patients with acute brucellosis in a centre of Iran.
    Razzaghi R; Rastegar R; Momen-Heravi M; Erami M; Nazeri M
    Indian J Med Microbiol; 2016; 34(3):342-5. PubMed ID: 27514957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.
    Liu ZG; Di DD; Wang M; Liu RH; Zhao HY; Piao DR; Zhao ZZ; Hao YQ; Du YN; Jiang H; Cui BY; Xia XZ
    BMC Infect Dis; 2018 Jan; 18(1):43. PubMed ID: 29338693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and therapy of infections with Brucella abortus and Brucella melitensis in humans].
    HUELS G; SCHMIDT W; STRAUCH D; WINTER H
    Medizinische; 1956 Oct; 24(40):1430-4. PubMed ID: 13377957
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of doxycycline, streptomycin, cotrimoxazole and rifamycin on the functions of normal human neutrophils against Brucella melitensis.
    Orduña A; Orduña C; Zarzosa P; Bratos MA; Ortiz de Lejarazu R; Rodríguez-Torres A
    J Chemother; 1989 Jul; 1(4 Suppl):429-31. PubMed ID: 16312472
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of prolonged antibiotic therapy in mice with chronic Brucella infection due to Brucella melitensis.
    SHAFFER JM; KUCERA CJ; SPINK WW
    J Immunol; 1953 Jan; 70(1):31-8. PubMed ID: 13035086
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro synergistic effects of a short cationic peptide and clinically used antibiotics against drug-resistant isolates of Brucella melitensis.
    Mohammadi Azad Z; Moravej H; Fasihi-Ramandi M; Masjedian F; Nazari R; Mirnejad R; Moosazadeh Moghaddam M
    J Med Microbiol; 2017 Jul; 66(7):919-926. PubMed ID: 28699872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
    Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
    Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization against Brucella infection. IV. Response of monkeys to injection of a streptomycin-dependent strain of Brucella melitensis.
    ELBERG SS; HENDERSON DW; HERZBERG M; PEACOCK S
    J Bacteriol; 1955 Jun; 69(6):643-8. PubMed ID: 14392120
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro assay for the anti-Brucella activity of medicinal plants against tetracycline-resistant Brucella melitensis.
    Motamedi H; Darabpour E; Gholipour M; Seyyed Nejad SM
    J Zhejiang Univ Sci B; 2010 Jul; 11(7):506-11. PubMed ID: 20593515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Diagnostic Aspects of Brucellosis and Antimicrobial Susceptibility of Brucella Isolates in Hamedan, Iran.
    Torkaman Asadi F; Hashemi SH; Alikhani MY; Moghimbeigi A; Naseri Z
    Jpn J Infect Dis; 2017 May; 70(3):235-238. PubMed ID: 27580575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.
    Deshmukh A; Hagen F; Sharabasi OA; Abraham M; Wilson G; Doiphode S; Maslamani MA; Meis JF
    BMC Microbiol; 2015 Jun; 15():121. PubMed ID: 26073177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of clinical isolates of Brucella melitensis to fucidic acid.
    Celik I; Cihangiroglu M; Denk A; Akbulut A
    J Infect Chemother; 2005 Apr; 11(2):101-3. PubMed ID: 15856380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility data for Brucella melitensis isolates cultured from UK patients.
    Cooke RP; Perrett L
    J Infect; 2014 Apr; 68(4):401. PubMed ID: 24440739
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis.
    Kilic S; Dizbay M; Cabadak H
    J Chemother; 2008 Feb; 20(1):33-7. PubMed ID: 18390405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological survey of rifampicin resistance in clinic isolates of Brucella melitensis obtained from all regions of Turkey.
    Sayan M; Kılıc S; Uyanık MH
    J Infect Chemother; 2012 Feb; 18(1):41-6. PubMed ID: 21826587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.